Why AGA Treatment Protocols Differ Even at the Same Norwood Stage — An Individualized Framework Using AGA Progression Rate, Family History, and Follicular Reserve with Stem Cell Conditioned Media, Explained by Dr. Moriwaki2026.08.16

“Same Norwood stage, so the same treatment” — this is a common misunderstanding heard at first AGA consultations. In actual clinical practice, however, the AGA progression rate varies significantly from person to person, and the treatment plan must be individually optimized based on the weight of family history and the amount of remaining follicular reserve. In regenerative approaches that incorporate stem cell conditioned media, the key is not to determine treatment intensity from the Norwood stage alone, but to design the intervention by multiplying AGA progression rate against remaining reserve.

Key Points of This Article

・Even at the same Norwood stage, a 2x difference in AGA progression rate can flip the treatment priority.

・Family history is used to estimate the “upper ceiling” of possible progression; follicular reserve is used to gauge “how much can still be recovered right now.”

・The earlier stem cell conditioned media is introduced while follicular reserve remains, the wider the area it can support.

・When the progression rate is fast, it makes sense to establish oral medication as the “stopping” foundation and run conditioned media alongside it.

・When progression is slow and reserve is preserved, conditioned media can serve as the main axis with flexible frequency design.

Three Axes That Separate Treatment Design at the Same Norwood Stage — AGA Progression Rate, Family History, and Follicular Reserve

1. AGA Progression Rate — “How Fast Is It Advancing Right Now?”

A Norwood classification is only a snapshot of the current moment. Without the time-axis information of how much has advanced in the past 6-12 months, one cannot predict how far it will progress next. A man whose hairline has clearly receded within half a year and a man who reached the same amount of recession over five years have completely different 6-month outlooks. In cases with a fast rate of progression, oral medication (finasteride/dutasteride) enzyme inhibition takes priority, and the timing of shifting conditioned media from “defense” to “offense” is then designed on top of that foundation.

2. Family History — Material for Predicting the “Ceiling”

How far male relatives on both the paternal and maternal side eventually progressed is important information for estimating the genetic background of susceptibility. However, even if a genetic test reports “high AGA risk,” that does not mean progression will necessarily occur at the same speed. Family history indicates a “reachable ceiling,” but whether one actually reaches it depends on the rate of progression and whether intervention is initiated. Even at Norwood III, a man whose family history suggests “likely to progress to VI” needs to build a long-term plan with a higher-intensity combination from an early stage.

3. Follicular Reserve — The Margin of “How Much Can Still Be Recovered”

The response to treatment fundamentally changes depending on whether the follicles in a thinning area have “completely disappeared” or “remain in a miniaturized, thin, and short state.” Under a microscope, indicators of follicular reserve include the variability of hair shaft diameter, the number of hairs per follicular unit, and the ratio of vellus to terminal hairs. Scalp treatment with stem cell conditioned media can be expected to “support the follicular microenvironment” precisely at the stage where follicles are functionally impaired by microinflammation. Conversely, in areas where the follicles themselves have been lost, conditioned media does not play a role in “newly growing” hair. Please also see our related column list on hair regenerative medicine.

Treatment Protocols Interpreted by Multiplying the Three Axes

Even if five men with Norwood III lined up, the combination of these three axes yields entirely different plans for “what to prioritize over the next three months from today.”

Case A: Fast Progression x Heavy Family History x Reserve Preserved

The highest priority is to “stop” the process. Oral medication that inhibits 5-alpha reductase, which produces DHT, is placed as the foundation to decelerate progression. Stem cell conditioned media is scheduled at 3-4 week intervals during the induction phase, and while the follicles are “protected,” the correction of chronic microinflammation and microcirculatory environment around the follicles is advanced. Here, conditioned media functions as a “complement that pushes recovery forward.”

Case B: Slow Progression x Light Family History x Reserve Preserved

Whether or not to introduce oral medication is discussed based on patient preference and side effect tolerance. Conditioned media is set as the axis, frequency is designed flexibly, and progress is observed on a months-long scale. When progression is slow, this is the phase in which conditioned media can approach a “leading role.” However, observation should not be halted; continuous monitoring for changes in progression rate is required.

Case C: Fast Progression x Heavy Family History x Depleted Reserve

Realistically, a conversation is needed to separate “areas that can be protected” from “areas that cannot be recovered.” For areas where follicles have been lost, alternative options including autologous hair transplantation are presented, and for the remaining follicles, density maintenance is pursued with oral medication plus conditioned media. Here, not overinflating expectations by assuming “conditioned media injection will bring it back” is the honest design for long-term continuation. For official guidelines on AGA treatment, please also refer to the Japanese Dermatological Association.

Information to Review at the First Visit to Support Individual Design

It is difficult to judge everything in the 30 minutes of a first visit, but carefully gathering at least the following information enables a design aligned with both wheels of progression rate and follicular reserve.

・Timeline of photos from the past 1-3 years, subjective changes in hair volume, and “what triggered awareness”

・Patterns of hair volume progression in male relatives on both paternal and maternal sides

・Hair shaft diameter histogram under microscope, number of hairs per follicular unit, vellus hair ratio

・Blood work (thyroid, ferritin, liver/kidney function, hormones as needed)

・Past medical history, current medications, prior AGA treatment history

These are materials for drawing a blueprint of “where to place treatment intensity.” If a hypothesis for the frequency and combination of stem cell conditioned media, the accompanying oral medication, and the initial design of the “treatment graduation timing” is set at the first visit, the efficacy assessment at 3 months becomes less variable. Individual design is not about “removing the template” but about “adjusting the template with information.”

Frequently Asked Questions

Q. My Norwood stage is the same as my friend’s, so why is the treatment different?

The Norwood classification is a snapshot of the “current appearance stage,” but the progression rate, the weight of family history, and follicular reserve differ per person. Even at the same stage, the range of how far it can progress in the next 6 months and how far it can be recovered differs, so the combination and intensity of treatment also change.

Q. How is AGA progression rate measured?

Past photos (ID photos, smartphone photos) and photos at the first visit are compared side by side under as similar conditions as possible. That is then combined with the patient’s subjective timing of change and microscopic findings at the first visit (hair shaft diameter variability, vellus ratio) to estimate progression speed. Progression rate cannot be measured from a single photo alone.

Q. Is there no meaning in injecting stem cell conditioned media into areas with depleted follicular reserve?

In areas where the follicles themselves have been completely lost, conditioned media is not a treatment to newly grow hair. However, it has meaning for environmental support in border areas and surrounding surviving follicles. Sharing expectations with the physician after separating “areas that cannot be recovered” from “areas that can be protected” is important.

Q. If family history is light, can I assume AGA won’t progress?

Family history is “material for estimating the reachable ceiling,” but not an absolute prediction. Multiple factors such as lifestyle, stress, and nutritional status are involved. Even with a light family history, if the actual rate of progression is fast, early intervention taking that into account is reasonable.

Q. Will the Norwood stage go down once I start treatment?

Whether the “appearance stage” improves depends on follicular reserve and the treatment combination. If re-thickening of miniaturized follicles or terminalization of vellus hairs occurs, the impression on the stage will improve, but this does not mean lost follicles themselves are “revived.” Honest expectation setting is the most important element for long-term continuation.

──────────────

Supervising Physician: Shin Moriwaki, M.D.

Member, Japan Society of Aesthetic Surgery (JSAS) / Member, American Academy of Aesthetic Medicine

ECFMG Certificate

──────────────

📍AVAN TOKYO Ginza Hair Regenerative Medicine

English / 中文 / Tiếng Việt available

Inquiries welcome via DM / LINE / Website / Phone.